Date Degree Awarded
Fall 12-16-2016
Degree Type
Open Access Dissertation
Degree Name
PHD in Applied Life Sciences
First Thesis/Dissertation Advisor
Mikhail Martchenko
Second Thesis/Dissertation Advisor
Animesh Ray
Third Thesis/Dissertation Advisor
Ian M Phillips
Terms of Use & License Information
Abstract
Drug resistance is a longstanding and still-increasing threat to the effective treatment of infectious diseases. Discovering drugs that target host proteins involved in pathogenicity is a strategy that could address this problem. Unfortunately, there are currently no FDA-approved infectious disease therapies that specifically target host proteins. Our goal is to develop a method to i) quickly discover new drugs for the treatment infectious diseases, ii) identify the specific host protein target of the drugs, iii) investigate the broad spectrum application of the drugs. To find these types of drugs, we employed a novel multiplex drug screening method in which we used disease pathway knowledge to more effectively screen a library of FDA-approved drugs. We utilized a cell-based survival assay to determine safety and efficacy and a biochemical-based assay to determine the host protein target of the drugs. This methodology led to the discovery of two FDA-approved drugs and their host protein targets. In addition, these drugs were shown to be safe and effective in animal models. These results suggest that our novel multiplex drug screening method can be used to address the drug resistance problem.
DOI
10.5642/kgitd/5
Recommended Citation
Leonardi, William. (2016). Multiplex Drug Screenings to Discover Host Oriented Therapies Against Infectious Diseases. KGI Theses and Dissertations, 5. https://scholarship.claremont.edu/kgi__theses/5. doi: 10.5642/kgitd/5